| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |